FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Triamcinolone Acetonide (Triesence) Injection, Suspension
Status: Resolved
»Duration of Shortage: 09/12/2019 - 01/21/2021
»Therapeutic Categories: Ophthalmology

Novartis (Revised 01/21/2021)

Company Contact Information:
888-669-6682

Presentation
  • Triesence (Triamcinolone acetonide injectable suspension) Vial 40mg/mL 1mL in 1 vial (NDC 0065-0543-01)
Note:
  • N/A

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English